Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Moodys
Cerilliant
UBS
Daiichi Sankyo
Novartis
Colorcon
Covington
Citi

Generated: October 17, 2017

DrugPatentWatch Database Preview

Griseofulvin, ultramicrocrystalline - Generic Drug Details

« Back to Dashboard

What are the generic sources for griseofulvin, ultramicrocrystalline and what is the scope of griseofulvin, ultramicrocrystalline freedom to operate?

Griseofulvin, ultramicrocrystalline
is the generic ingredient in six branded drugs marketed by Wyeth Ayerst, Pliva, and Chartwell Rx, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for griseofulvin, ultramicrocrystalline.

Summary for Generic Name: griseofulvin, ultramicrocrystalline

US Patents:0
Tradenames:6
Applicants:3
NDAs:5
Drug Master File Entries: see list1
Bulk Api Vendors: see list50
Clinical Trials: see list9
Patent Applications: see list6,263
Drug Prices:see low prices
DailyMed Link:griseofulvin, ultramicrocrystalline at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pliva
ULTRAGRIS-165
griseofulvin, ultramicrocrystalline
TABLET;ORAL062645-001Jun 30, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
GRISACTIN ULTRA
griseofulvin, ultramicrocrystalline
TABLET;ORAL062438-002Nov 17, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Chartwell Rx
FULVICIN P/G
griseofulvin, ultramicrocrystalline
TABLET;ORAL061996-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
GRISACTIN ULTRA
griseofulvin, ultramicrocrystalline
TABLET;ORAL062178-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Chartwell Rx
FULVICIN P/G
griseofulvin, ultramicrocrystalline
TABLET;ORAL061996-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
GRISACTIN ULTRA
griseofulvin, ultramicrocrystalline
TABLET;ORAL062438-001Nov 17, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Chartwell Rx
FULVICIN P/G 330
griseofulvin, ultramicrocrystalline
TABLET;ORAL061996-004Apr 6, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
GRISACTIN ULTRA
griseofulvin, ultramicrocrystalline
TABLET;ORAL062178-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Chartwell Rx
FULVICIN P/G 165
griseofulvin, ultramicrocrystalline
TABLET;ORAL061996-003Apr 6, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pliva
ULTRAGRIS-330
griseofulvin, ultramicrocrystalline
TABLET;ORAL062646-001Jun 30, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Cerilliant
Colorcon
Cipla
Accenture
Boehringer Ingelheim
Baxter
Julphar
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot